Brief: Pharma Equity Maintains Financial Guidance For 2026
14/08/2026 08:51
BRIEF-Pharma Equity Maintains Financial Guidance For 2026 Aug 14 (Reuters) - Pharma Equity Group A/S PEGRP.CO:
MAINTAINS ITS FINANCIAL GUIDANCE FOR 2026
H1 LOSS DKK 2.7 MILLION
Source text: ID:nGNE6vmPDt
Further company coverage: PEGRP.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations